Skip to main content
HR 1393 118th Congress House Crime and Law Enforcement

To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.

Introduced: July 19, 2023 Introduced by: Dean, Madeleine Democratic · Pennsylvania See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 17, 2023
Referred to the Subcommittee on Health.
Mar 7, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 7, 2023
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

This bill provides for the classification of drugs or other substances that are part of approved breakthrough therapies as schedule II controlled substances under the Controlled Substances Act. (Schedule II controlled substances are substances that have a high potential for abuse but have a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.)

What's happening now March 17, 2023

Referred to the Subcommittee on Health.

 Related & companion bills 1
  • S 689 Related bill A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and fo…
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Lobbying activity 6

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

 Cosponsors 18
All 18 Democratic 6 Republican 7
R
Baird, James R.
Indiana · Jul 2, 2024
Jackson Lee, Sheila
· Jul 2, 2024
 R
Nunn, Zachary
Iowa · Jul 2, 2024
 D
Watson Coleman, Bonnie
New Jersey · Jul 2, 2024
Allred, Colin
· Mar 8, 2024
 R
Bacon, Don
Nebraska · Mar 8, 2024
 D
Lieu, Ted
California · Mar 8, 2024
 D
Thompson, Mike
California · Mar 8, 2024
 R
Van Orden, Derrick
Wisconsin · Mar 8, 2024
 D
Garcia, Robert
California · Jul 19, 2023
 D
Khanna, Ro
California · Jul 19, 2023
 R
Miller-Meeks, Mariannette
Iowa · Jul 19, 2023
Williams, Brandon
· Jul 19, 2023
 D
Crockett, Jasmine
Texas · Jun 23, 2023
 R
Luttrell, Morgan
Texas · Jun 23, 2023
Blumenauer, Earl
· May 25, 2023
Johnson, Bill
· May 25, 2023
 R
Mace, Nancy
South Carolina · Mar 7, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1393: To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.. 118th Congress. Open America. https://openamerica.io/bill/118-HR-1393/
MLA
"H.R. 1393: To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-1393/.
Bluebook (legal)
H.R. 1393, 118th Cong. (2026), https://openamerica.io/bill/118-HR-1393/.
Markdown link
[H.R. 1393: To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.](https://openamerica.io/bill/118-HR-1393/)
Report a problem